{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:27:54Z","timestamp":1793838474932,"version":"4.6.1"},"reference-count":23,"publisher":"Impact Journals, LLC","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,6,12]]},"DOI":"10.18632\/oncotarget.25137","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T14:50:33Z","timestamp":1528728633000},"page":"27595-27604","source":"Crossref","is-referenced-by-count":14,"title":["Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with <i>ALK<\/i> rearrangement and loss of 14q"],"prefix":"10.18632","volume":"9","author":[{"given":"Carsten","family":"Holzmann","sequence":"first","affiliation":[{"name":"Institute of Medical Genetics, University Rostock Medical Center, Rostock D-18057, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Saager","sequence":"additional","affiliation":[{"name":"Clinic Dr. Hancken, Stade D-21680, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild","family":"Mechtersheimer","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg D-69120, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Koczan","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Rostock Medical Center, Rostock D-18057, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard M.","family":"Helmke","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Elbe Clinics, Stade D-21682, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Bullerdiek","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics, University Rostock Medical Center, Rostock D-18057, Germany"},{"name":"Human Genetics, University of Bremen, Bremen D-28359, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"1","unstructured":"FDA, U.S. Food and Drug Administration. Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication. Center for Devices and Radiological Health; 2014. p. Available at: https:\/\/wayback.archive-it.org\/7993\/20170722215731\/https:\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm393576.htm."},{"key":"2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","article-title":"Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study","volume":"144","author":"Lorusso","year":"2017","journal-title":"Gynecol Oncol"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.11.1039","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications","volume":"216","author":"Rutstein","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/bjc.2012.428","article-title":"Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer","volume":"107","author":"Levine","year":"2012","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/gcc.22029","article-title":"MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors","volume":"52","author":"Bullerdiek","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/modpathol.2009.96","article-title":"Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas","volume":"22","author":"Toruner","year":"2009","journal-title":"Mod Pathol"},{"key":"7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ygyno.2006.08.034","article-title":"Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas","volume":"104","author":"Joutovsky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00404-015-3696-z","article-title":"Malignancy rate of 10, 731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH)","volume":"292","author":"Tchartchian","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation","volume":"127","author":"Lentz","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejogrb.2015.11.009","article-title":"Incidence of occult leiomyosarcoma in presumed morcellation cases: A database study","volume":"197","author":"Kilic","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ijgo.12111","article-title":"Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease","volume":"137","author":"Elkadry","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/jog.13240","article-title":"Morcellating uterine mesenchymal tumors: The pathologist\u2019s view","volume":"43","author":"Panoskaltsis","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"e50058","DOI":"10.1371\/journal.pone.0050058","volume-title":"PLoS One","volume":"7","author":"Sullivan","year":"2012"},{"key":"14","first-page":"6445","article-title":"Patterns of chromosomal abnormalities that can improve diagnosis of uterine smooth muscle tumors","volume":"35","author":"Bullerdiek","year":"2015","journal-title":"Anticancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1056\/NEJMms1516161","volume-title":"NEJM","volume":"374","author":"Malina","year":"2016"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.03.006","article-title":"Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: A decision analysis","volume":"212","author":"Clarke-Pearson","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/modpathol.2016.129","article-title":"Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas. Mod Pathol","volume":"29","author":"Heim","year":"2016","journal-title":"Nature Publishing Group"},{"key":"18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1","volume":"41","author":"Lee","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13045-015-0160-2","article-title":"STUMP un\u201cstumped\u201d: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol","volume":"8","author":"Brennan","year":"2015","journal-title":"BioMed Central"},{"key":"20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/1471-0528.13541","article-title":"Parasitic myoma after laparoscopic morcellation: a systematic review of the literature","volume":"123","author":"Bongers","year":"2016","journal-title":"BJOG"},{"key":"21","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","article-title":"MED12 mutations in uterine fibroids - their relationship to cytogenetic subgroups","volume":"131","author":"Bullerdiek","year":"2012","journal-title":"Int J Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gcc.20291","article-title":"Uterine leiomyomata with deletions of 1p represent a distinct cytogenetic subgroup associated with unusual histologic features","volume":"45","author":"Morton","year":"2006","journal-title":"Genes Chromosom Cancer"},{"key":"23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Virolainen","year":"2011","journal-title":"Science"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T18:34:10Z","timestamp":1589049250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":23,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018,6,12]]}},"alternative-id":["25137","29963223"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25137","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}